Literature DB >> 1735170

Coronary cyclic flow variations "precondition" ischemic myocardium.

M Ovize1, R A Kloner, S L Hale, K Przyklenk.   

Abstract

BACKGROUND: Repeated brief episodes of myocardial ischemia performed by mechanical clamping of a coronary artery "precondition" the heart and reduce infarct size after a subsequent sustained ischemia. It is not known, however, whether spontaneous episodes of transient ischemia caused by formation of platelet thrombi, which may occur in unstable angina, have a similar cardioprotective effect. METHODS AND
RESULTS: Therefore, our objective was to determine whether brief spontaneous thrombotic episodes of ischemia/reperfusion could limit infarct size and preserve contractile function following 60 minutes (protocol 1) or 90 minutes (protocol 2) of sustained ischemia and 4-4.5 hours of reperfusion in the canine model. Before the sustained coronary occlusion, dogs underwent a 30-minute "treatment" period consisting of: no intervention (control group), four repeated episodes of 3-minute mechanical occlusion plus 5-minute reperfusion (preconditioned group), or coronary artery stenosis and endothelial injury, resulting in a mean of four spontaneous episodes of cyclic flow variations (CFV group) caused by formation and dislodgment of platelet thrombi. In protocol 1 (60-minute sustained ischemia plus 4.5-hour reperfusion), infarct size was significantly smaller in both the preconditioned and CFV groups compared with controls (3.5 +/- 1.4%,* 3.4 +/- 2.1%,* and 9.9 +/- 2.7% of the myocardium at risk, respectively; *p less than 0.05 versus control). In contrast, neither preconditioning nor CFV preserved contractile function: Segment shortening during sustained occlusion was equally depressed at -15% to -20% of baseline values among the three groups and equally stunned at +12% to +18% of baseline during the 4.5 hours of reflow. In protocol 2 (90-minute sustained ischemia plus 4-hour reperfusion), only CFV continued to exert a cardioprotective effect: Infarct size averaged 15.0 +/- 4.1%, 7.4 +/- 2.5%,* and 16.5 +/- 4.4% of the region at risk in the preconditioned, CFV, and control groups, respectively (*p less than 0.05 versus control). Contractile function, however, was similar among all three groups both during 90 minutes of sustained occlusion and throughout 4 hours of reperfusion.
CONCLUSIONS: We therefore conclude that repeated coronary thrombus formation preconditions the ischemic myocardium: In fact, in contrast to mechanical preconditioning, cardioprotection provided by CFV persisted following 90 minutes of sustained coronary occlusion. However, preconditioning by thrombotic or mechanical occlusion neither preserved myocardial contractile function during sustained coronary occlusion nor prevented stunning after reperfusion. These data raise the possibility that clinical episodes of unstable angina prior to acute myocardial infarction may precondition the ischemic myocardium.

Entities:  

Mesh:

Year:  1992        PMID: 1735170     DOI: 10.1161/01.cir.85.2.779

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Preconditioning: a balanced perspective.

Authors:  K Przyklenk; R A Kloner
Journal:  Br Heart J       Date:  1995-12

4.  Reduction of infarct size in vivo with ischemic preconditioning: mathematical evidence for protection via non-ischemic tissue.

Authors:  P Whittaker; K Przyklenk
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

5.  Is warm-up in angina ischaemic preconditioning?

Authors:  M S Marber; M D Joy; D M Yellon
Journal:  Br Heart J       Date:  1994-09

6.  Hypoxia/reoxygenation-induced upregulation of miRNA-542-5p aggravated cardiomyocyte injury by repressing autophagy.

Authors:  Fei Wang; Xin Min; Shan-You Hu; Da-Li You; Ting-Ting Jiang; Li Wang; Xiao Wu
Journal:  Hum Cell       Date:  2021-01-04       Impact factor: 4.174

Review 7.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

8.  The impact of sex and myocardial ischemic preconditioning on immunohistochemical markers of acute myocardial infarction.

Authors:  K Scholl; R Huhn; St Ritz-Timme; F Mayer
Journal:  Int J Legal Med       Date:  2018-10-23       Impact factor: 2.686

Review 9.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

10.  Transient pre-ischemic acidosis protects the isolated rabbit heart subjected to 30 minutes, but not 60 minutes, of global ischemia.

Authors:  B Z Simkhovich; P Whittaker; K Przyklenk; R A Kloner
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.